Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCLA: Influence of Omeprazole on Clopidogrel Anti-Platelet Action
NCT00349661Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronary heart disease (CHD) comparing Omeprazole with Placebo (2 arms). Primary endpoint: Vasodilator-Stimulated Phosphoprotein (VASP) test at 7 days. Started Jun 2006; status: completed.
02
Drugs
omeprazole
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00349661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00349661.